With high investment needs and long research and approval cycles, funding innovation is especially difficult in the biotech and life sciences. As the biotech and life science sector continues to find ways to fund innovative research to develop therapies and medicines for tomorrow’s healthcare, companies must also prioritize and target investment and alliance activity.
Grant Thornton’s Insights for Life Sciences Business Funding Strategies was published in 2009 but still has relevance today. The report was created with their client experience and analysis of transaction activity. They identified three key steps that life sciences executives should take to maximize their odds of receiving and capitalizing on investment funding:
- Critically evaluate and rank their portfolio of research programs and products
- Identify internal and external options for continued portfolio development
- Determine an optimal funding strategy for their business
The report also provides further insight and examples for:
- Life sciences funding
- Funding trends
- Investment focus and alignment
- Aligning capabilities and partners
- Deal term trends
- Alternative funding sources
- Creating a strategic focus
- Determining an optimal funding strategy
